Type 2 Diabetes – Novo Nordisk – NN2211-4232

Location: Colorado Springs

Stay: None

Gender: Male/Female

Ages: 18+

Compensation: $60

Smokers Allowed: Yes

Study Overview:

To compare the efficacy in controlling glycaemia with Victoza® (liraglutide) as add-on to metformin vs. OADs as add-on to metformin after up to 104 weeks of treatment in subjects with T2D treated in primary care, inadequately controlled with metformin monotherapy.

Enroll In This Study